GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 111 filers reported holding GOSSAMER BIO INC in Q1 2023. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,000 | -25.0% | 3,150 | -6.4% | 0.00% | – |
| Q2 2023 | $4,000 | -71.4% | 3,365 | -70.8% | 0.00% | – |
| Q1 2023 | $14,000 | -62.2% | 11,532 | -33.1% | 0.00% | – |
| Q4 2022 | $37,000 | +94.7% | 17,246 | +961.3% | 0.00% | – |
| Q3 2022 | $19,000 | +375.0% | 1,625 | +218.6% | 0.00% | – |
| Q2 2022 | $4,000 | -93.4% | 510 | -92.8% | 0.00% | – |
| Q1 2022 | $61,000 | -53.8% | 7,112 | -39.0% | 0.00% | – |
| Q4 2021 | $132,000 | +80.8% | 11,650 | +99.9% | 0.00% | – |
| Q3 2021 | $73,000 | -84.5% | 5,827 | -89.9% | 0.00% | – |
| Q2 2021 | $470,000 | +1205.6% | 57,880 | +1407.3% | 0.00% | – |
| Q1 2021 | $36,000 | +56.5% | 3,840 | +62.0% | 0.00% | – |
| Q4 2020 | $23,000 | +91.7% | 2,370 | +137.0% | 0.00% | – |
| Q3 2020 | $12,000 | -14.3% | 1,000 | -6.1% | 0.00% | – |
| Q2 2020 | $14,000 | +600.0% | 1,065 | +485.2% | 0.00% | – |
| Q1 2020 | $2,000 | -98.3% | 182 | -97.6% | 0.00% | – |
| Q4 2019 | $118,000 | +40.5% | 7,546 | +50.9% | 0.00% | – |
| Q3 2019 | $84,000 | -45.5% | 5,000 | -28.2% | 0.00% | – |
| Q2 2019 | $154,000 | +42.6% | 6,967 | +39.3% | 0.00% | – |
| Q1 2019 | $108,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |